罕见病研究2024,Vol.3Issue(3) :368-374.DOI:10.12376/j.issn.2097-0501.2024.03.015

原发性纤毛运动障碍患者外显子组测序阴性后的遗传诊断思路

The Expanding Genetic Diagnostic Approaches for Patients with Primary Ciliary Dyskinesia Beyond the Exome

李奕璇 何苗 郑海霞 刘雅萍
罕见病研究2024,Vol.3Issue(3) :368-374.DOI:10.12376/j.issn.2097-0501.2024.03.015

原发性纤毛运动障碍患者外显子组测序阴性后的遗传诊断思路

The Expanding Genetic Diagnostic Approaches for Patients with Primary Ciliary Dyskinesia Beyond the Exome

李奕璇 1何苗 1郑海霞 1刘雅萍2
扫码查看

作者信息

  • 1. 中国医学科学院基础医学研究所北京协和医学院基础学院麦库西克-张孝骞协和遗传医学中心疑难重症及罕见病全国重点实验室,北京 100005
  • 2. 中国医学科学院北京协和医院临床医学研究所,北京 100730
  • 折叠

摘要

原发性纤毛运动障碍(PCD)是一种罕见的单基因遗传病,主要与动纤毛结构和功能障碍有关,多呈常染色体隐性遗传.该疾病会累及多个器官,并且患者的临床表型与遗传异质性为其诊断带来了极大的困难.尽管临床上外显子组测序的使用大大提高了 PCD的诊断率,但仍有约30%以上的患者未能得到有效的诊断.本文对PCD的发病机制、诊断方法及外显子组测序阴性后的诊断思路和新兴遗传检测技术进行综述和探讨,以期帮助临床医师进一步选择更多的新兴遗传检测方法,从而提高PCD的阳性诊断率,并提高临床医师对其遗传致病机制的深刻理解,为将来实践基因治疗奠定基础.

Abstract

Primary ciliary dyskinesia(PCD)is a rare monogenic disorder primarily associated with structural and functional abnormalities of motile cilia.It is typically inherited in an autosomal recessive pattern.The disease affects multiple organs,and the variability in clinical phenotypes,along with genetic heterogeneity significantly complicates its diagnosis.Although the application of clinical exome sequencing has significantly improved the diagnostic rate of PCD,more than 30%of patients are still unable to obtain a definitive diagno-sis.This article reviews and discusses the pathogenesis,diagnostic methods,and expanding genetic diag-nostic approaches for patients with PCD that are negative for exome sequencing.The aim of this article is to assist clinicians in selecting more advanced emerging genetic testing technologies,with the hope of increasing the positive diagnostic rate of PCD,deepening the understanding of its genetic pathogenesis,and laying a foundation for the practice of gene therapy in the future.

关键词

原发性纤毛运动障碍/外显子组测序/新兴遗传检测技术/基因诊断率

Key words

primary ciliary dyskinesia/exome sequencing/emerging genetic testing technologies/genetic diagnostic rate

引用本文复制引用

基金项目

中央高水平医院临床科研业务费(2023-PUMCH-E-012)

出版年

2024
罕见病研究

罕见病研究

CSTPCD
ISSN:
参考文献量3
段落导航相关论文